Clinical Trials Browser

Phase 1 × Withdrawn × exemestane × Clear all

NCT01240928 2013-08-20

MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms